{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T13:02:14Z","timestamp":1776258134750,"version":"3.50.1"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Hematol"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1007\/s12185-025-04121-x","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T06:44:20Z","timestamp":1764139460000},"page":"535-543","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comprehensive anticoagulant effect of heparinoid in blood samples from patients with hemophilia"],"prefix":"10.1007","volume":"123","author":[{"given":"Tomoya","family":"Miyatake","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9348-9815","authenticated-orcid":false,"given":"Masahiro","family":"Takeyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Horiuchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"key":"4121_CR1","first-page":"92","volume":"79","author":"D Bergqvist","year":"1990","unstructured":"Bergqvist D, Brunkwall J, Jensen N, Persson NH. Treatment of superficial thrombophlebitis. A comparative trial between placebo, Hirudoid cream and piroxicam gel. Ann Chir Gynaecol. 1990;79:92\u20136.","journal-title":"Ann Chir Gynaecol"},{"key":"4121_CR2","unstructured":"NHS. Heparinoid: medicine for bruises, haematoma and swollen veins. NHS Health A to Z. 2022."},{"key":"4121_CR3","doi-asserted-by":"publisher","first-page":"7093","DOI":"10.3390\/molecules28207093","volume":"28","author":"Y Li","year":"2023","unstructured":"Li Y, et al. A review of chondroitin sulfate\u2019s preparation, properties, functions, and applications. Molecules. 2023;28:7093.","journal-title":"Molecules"},{"key":"4121_CR4","doi-asserted-by":"publisher","first-page":"1705","DOI":"10.3324\/haematol.2019.221093","volume":"104","author":"G Castaman","year":"2019","unstructured":"Castaman G, Matino D. Hemophilia A and B: molecular and clinical similarities and differences. Haematologica. 2019;104:1705\u201312.","journal-title":"Haematologica"},{"key":"4121_CR5","volume-title":"Hemophilia: a review of inherited bleeding disorders","author":"ID Walker","year":"2024","unstructured":"Walker ID, Nair V. Hemophilia: a review of inherited bleeding disorders. StatPearls; 2024."},{"key":"4121_CR6","doi-asserted-by":"publisher","first-page":"1773","DOI":"10.1056\/NEJM200106073442307","volume":"344","author":"PM Mannucci","year":"2001","unstructured":"Mannucci PM, Tuddenham EG. The hemophilias\u2014from royal genes to gene therapy. N Engl J Med. 2001;344:1773\u20139.","journal-title":"N Engl J Med"},{"key":"4121_CR7","first-page":"2391","volume":"19","author":"EC Rodriguez-Merchan","year":"2021","unstructured":"Rodriguez-Merchan EC, Mannucci PM. Hemophilic arthropathy: current knowledge and future perspectives. J Thromb Haemost. 2021;19:2391\u2013406.","journal-title":"J Thromb Haemost"},{"key":"4121_CR8","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1055\/s-0037-1615621","volume":"85","author":"GC White II","year":"2001","unstructured":"White GC II, Rosendaal F, Aledort LM, Lusher JM, Rothschild C, Ingerslev J. Definitions in hemophilia. Recommendation of the scientific subcommittee on factor VIII and factor IX of the scientific and standardization committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost. 2001;85:560.","journal-title":"Thromb Haemost."},{"key":"4121_CR9","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1055\/s-0042-1756706","volume":"49","author":"K Nogami","year":"2023","unstructured":"Nogami K. Clot waveform analysis for monitoring hemostasis. Semin Thromb Hemost. 2023;49:592\u20139.","journal-title":"Semin Thromb Hemost"},{"key":"4121_CR10","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1111\/jth.12987","volume":"13","author":"S Furukawa","year":"2015","unstructured":"Furukawa S, Nogami K, Ogiwara K, Yada K, Shima M. Systematic monitoring of hemostatic management in hemophilia A patients with inhibitor in the perioperative period using rotational thromboelastometry. J Thromb Haemost. 2015;13:1279\u201384.","journal-title":"J Thromb Haemost"},{"key":"4121_CR11","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s44313-024-00018-6","volume":"59","author":"D Gupta","year":"2024","unstructured":"Gupta D, Arya V, Dass J, Gupta N, Kalra M, Sachdeva A, et al. Assessment of the phenotypic severity of hemophilia A: using rotational thromboelastometry (ROTEM) and APTT-clot waveform analysis. Blood Res. 2024;59:19.","journal-title":"Blood Res"},{"key":"4121_CR12","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1538-7836.2006.01730.x","volume":"4","author":"T Matsumoto","year":"2006","unstructured":"Matsumoto T, Nogami K, Tabuchi Y, Yada K, Shima M. The measurement of low levels of factor VIII or factor IX in hemophilia A and hemophilia B plasma by clot waveform analysis and thrombin generation assay. J Thromb Haemost. 2006;4:377\u201384.","journal-title":"J Thromb Haemost"},{"key":"4121_CR13","doi-asserted-by":"publisher","first-page":"e427","DOI":"10.1111\/hae.13266","volume":"23","author":"T Matsumoto","year":"2017","unstructured":"Matsumoto T, Nogami K, Tabuchi Y, Yada K, Ogiwara K, Kurono H, et al. Clot waveform analysis using CS-2000i distinguishes between very low and absent levels of factor VIII activity in patients with severe haemophilia A. Haemophilia. 2017;23:e427\u201335.","journal-title":"Haemophilia"},{"key":"4121_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s12185-019-02698-8","volume":"110","author":"K Yada","year":"2019","unstructured":"Yada K, Nogami K, Ogiwara K, Shida Y, Furukawa S, Yaoi H, et al. Global coagulation function assessed by rotational thromboelastometry predicts coagulation-steady state in individual hemophilia A patients receiving emicizumab prophylaxis. Int J Hematol. 2019;110:419\u201330.","journal-title":"Int J Hematol"},{"key":"4121_CR15","first-page":"849","volume":"17","author":"K Ishikawa","year":"1955","unstructured":"Ishikawa K, Kawase S, Sugiyama T, Ohno S. About Hirudoid, a coagulation-inhibiting ointment. Geka. 1955;17:849\u201354.","journal-title":"Geka"},{"key":"4121_CR16","first-page":"1079","volume":"50","author":"A Iwama","year":"2013","unstructured":"Iwama A, Suzuki Y, Nishihori Y, Wada C. Bioequivalence study of BESOFTEN OILY CREAM 0.3%. Shinryo to Shinyaku (Med Cons New-Remed) . 2013;50:1079\u201386 (in Japanese).","journal-title":"Shinryo to Shinyaku (Med Cons New-Remed) ."},{"key":"4121_CR17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1021\/bi00507a028","volume":"20","author":"LT Mimms","year":"1981","unstructured":"Mimms LT, Zampighi G, Nozaki Y, Tanford C, Reynolds JA. Phospholipid vesicle formation and transmembrane protein incorporation using octyl glucoside. Biochemistry. 1981;20:833\u201340.","journal-title":"Biochemistry"},{"key":"4121_CR18","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1111\/jth.14022","volume":"16","author":"K Nogami","year":"2018","unstructured":"Nogami K, Matsumoto T, Tabuchi Y, Soeda T, Arai N, Kitazawa T, et al. Modified clot waveform analysis to measure plasma coagulation potential in the presence of the anti-factor IXa\/factor X bispecific antibody emicizumab. J Thromb Haemost. 2018;16:1078\u201388.","journal-title":"J Thromb Haemost"},{"key":"4121_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics10020118","author":"J Hartmann","year":"2020","unstructured":"Hartmann J, Murphy M, Dias JD. Viscoelastic hemostatic assays: moving from the laboratory to the site of care-a review of established and emerging technologies. Diagnostics. 2020. https:\/\/doi.org\/10.3390\/diagnostics10020118.","journal-title":"Diagnostics"},{"key":"4121_CR20","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1080\/00365513.2017.1394487","volume":"77","author":"P Jilma-Stohlawetz","year":"2017","unstructured":"Jilma-Stohlawetz P, Fritsche-Polanz S, Quehenberger P, Sch\u00f6rgenhofer C, Bartko J, Ristl R, et al. Evaluation of between-, within- and day-to-day variation of coagulation measured by rotational thrombelastometry (ROTEM). Scand J Clin Lab Invest. 2017;77:651\u20137.","journal-title":"Scand J Clin Lab Invest"},{"key":"4121_CR21","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1007\/s12185-022-03528-0","volume":"117","author":"F Shibasaki","year":"2023","unstructured":"Shibasaki F, Takeyama M, Ogiwara K, Furukawa S, Nakajima Y, Shimonishi N, et al. High levels of factor VIII activity in patients with acquired hemophilia A in remission are associated with unusually low coagulation potentials. Int J Hematol. 2023;117:669\u201377.","journal-title":"Int J Hematol"},{"key":"4121_CR22","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1111\/hae.14902","volume":"30","author":"M Takeyama","year":"2024","unstructured":"Takeyama M, Furukawa S, Ogiwara K, Tamura S, Ohno H, Higasa S, et al. Coagulation potentials of plasma-derived factors VIIa and X mixture (Byclot\u00ae) evaluated by global coagulation assay in patients with acquired haemophilia A. Haemophilia. 2024;30:249\u201352.","journal-title":"Haemophilia"},{"key":"4121_CR23","first-page":"109","volume":"34","author":"A Fujimura","year":"2018","unstructured":"Fujimura A, Miyawaki H, Honda N, Ohashi M. Equivalence study of the effect of Hirudoid\u00ae foam formulation on enhancement of stratum corneum moisture retention in healthy adult males. Rinsho Iyaku (Jpn J Clin Pharmacol Ther). 2018;34:109\u201314.","journal-title":"Rinsho Iyaku (Jpn J Clin Pharmacol Ther)"},{"key":"4121_CR24","doi-asserted-by":"publisher","first-page":"43390","DOI":"10.1074\/jbc.M112.412676","volume":"287","author":"N Sugiura","year":"2016","unstructured":"Sugiura N, Shioiri T, Chiba M, Sato T, Narimatsu H, Kimata K. Sequence determination of synthesized chondroitin sulfate chains: repeating disaccharide structure of glucuronic acid and N\u2011acetyl\u2011d\u2011galactosamine. Glycobiol\/J Biol Chem. 2016;287:43390\u2013400.","journal-title":"Glycobiol\/J Biol Chem"},{"key":"4121_CR25","unstructured":"Kyowa Pharmaceutical Co L. Interview Form for Sodium Chondroitin Sulfate 200\u00a0mg Injection \u201cUji\u201d: KYOWA Pharmaceutical Co., Ltd. ER; 2012."},{"key":"4121_CR26","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1034\/j.1600-0625.2000.009003165.x","volume":"9","author":"JD Bos","year":"2000","unstructured":"Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9:165\u20139.","journal-title":"Exp Dermatol"},{"key":"4121_CR27","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1002\/jat.1773","volume":"32","author":"A Chiang","year":"2012","unstructured":"Chiang A, Tudela E, Maibach HI. Percutaneous absorption in diseased skin: an overview. J Appl Toxicol. 2012;32:537\u201363.","journal-title":"J Appl Toxicol"},{"key":"4121_CR28","doi-asserted-by":"publisher","first-page":"175","DOI":"10.2491\/jjsth.17.175","volume":"17","author":"Y Ueno","year":"2006","unstructured":"Ueno Y, Oku K. Percutaneous absorption and pharmacological characteristics of heparinoid-containing topical formulations. Jpn J Thromb Hemost. 2006;17:175\u201382.","journal-title":"Jpn J Thromb Hemost"},{"key":"4121_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/1076029620912027","volume":"26","author":"H Wada","year":"2020","unstructured":"Wada H, Matsumoto T, Ohishi K, Shiraki K, Shimaoka M. Update on the clot waveform analysis: APTT\u2011CWA for quantitative evaluation of coagulation kinetics. Clin Appl Thromb Hemost. 2020;26:1\u20138.","journal-title":"Clin Appl Thromb Hemost"},{"key":"4121_CR30","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/ajh.23599","volume":"89","author":"D Whiting","year":"2014","unstructured":"Whiting D, DiNardo JA. TEG and ROTEM: technology and clinical applications. Am J Hematol. 2014;89:228\u201332.","journal-title":"Am J Hematol"},{"key":"4121_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/0049-3848(82)90078-0","volume":"27","author":"M Staudt","year":"1982","unstructured":"Staudt M, Bjornsson TD, Nash PV, Merritt AD. The anticoagulant effect of chondroitin-4-sulfate. Thromb Res. 1982;27:311\u201322.","journal-title":"Thromb Res"},{"key":"4121_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0193482","volume":"13","author":"J Hogwood","year":"2018","unstructured":"Hogwood J, Naggi A, Torri G, Page C, Rigsby P, Gray E, et al. The effect of increasing the sulfation level of chondroitin sulfate on anticoagulant specific activity and activation of the kinin system. PLoS ONE. 2018;13:e0193482.","journal-title":"PLoS ONE"},{"key":"4121_CR33","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.bcp.2009.04.012","volume":"78","author":"B Li","year":"2009","unstructured":"Li B, Suwan J, Martin JG, Zhang F, Zhang Z, Hoppensteadt D, et al. Oversulfated chondroitin sulfate interaction with heparin-binding proteins: new insights into adverse reactions from contaminated heparins. Biochem Pharmacol. 2009;78:292\u2013300.","journal-title":"Biochem Pharmacol"},{"key":"4121_CR34","doi-asserted-by":"publisher","first-page":"6713","DOI":"10.1016\/S0021-9258(18)32276-2","volume":"258","author":"DM Tollefsen","year":"1983","unstructured":"Tollefsen DM, Pestka CA, Monafo WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem. 1983;258:6713\u20136.","journal-title":"J Biol Chem"},{"key":"4121_CR35","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1160\/TH04-10-0706","volume":"93","author":"Y Dargaud","year":"2005","unstructured":"Dargaud Y, B\u00e9guin S, Lienhart A, Al Dieri R, Trzeciak C, Bordet JC, et al. Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thromb Haemost. 2005;93:475\u201380.","journal-title":"Thromb Haemost"},{"key":"4121_CR36","first-page":"849","volume":"17","author":"K Ishikawa","year":"1955","unstructured":"Ishikawa K, Kawase S, Sugiyama T, Ohno S. About Hirudoid, a coagulation-inhibiting ointment. Geka. 1955;17:849\u201354 (in Japanese).","journal-title":"Geka"}],"container-title":["International Journal of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12185-025-04121-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12185-025-04121-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T11:56:45Z","timestamp":1776254205000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12185-025-04121-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["4121"],"URL":"https:\/\/doi.org\/10.1007\/s12185-025-04121-x","relation":{},"ISSN":["0925-5710","1865-3774"],"issn-type":[{"value":"0925-5710","type":"print"},{"value":"1865-3774","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"2 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 November 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"K.N. is a member of the IJH Editorial Board. The other authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}